# Lab Report

**Document ID:** doc_8f17c3b2-9e0a-4d61-b75f-2a4c1e0d9f8e
**Date Created:** 2024-05-15

---

## Patient Information

*   **Patient ID:** P-987654
*   **Name:** Sarah Miller
*   **Date of Birth:** 1988-03-22
*   **Gender:** Female
*   **Address:** 789 Oak Avenue, Anytown, CA 90210
*   **Contact Number:** 555-123-4567

---

## Clinician Information

*   **Clinician ID:** C-112233
*   **Name:** Dr. Emily White
*   **Specialization:** General Practitioner
*   **Institution:** City General Hospital
*   **Contact Email:** emily.white@hospital.org

---

## Chief Complaint

Persistent fatigue and occasional dizziness.

---

## History of Present Illness

Patient reports experiencing fatigue for the past 3 months, worsening over the last month. Describes it as constant tiredness not relieved by rest. Occasional lightheadedness, especially when standing up quickly. No fever, chills, or significant weight changes reported. Denies shortness of breath or chest pain. Diet is described as balanced, and sleep patterns are regular (7-8 hours per night).

---

## Past Medical History

Childhood asthma (controlled, last exacerbation >10 years ago). No known allergies. No previous surgeries. Immunizations up to date.

---

## Vitals

*   **Temperature:** 36.8 Â°C
*   **Blood Pressure:** 118/76 mmHg
*   **Heart Rate:** 72 bpm
*   **Respiratory Rate:** 16 breaths/min
*   **Oxygen Saturation:** 98.0%

---

## Physical Exam

**General:** Alert and oriented, appears well-nourished, no acute distress.
**HEENT:** Normocephalic, atraumatic. Conjunctivae pink, sclerae anicteric. Oropharynx clear.
**Neck:** Supple, no lymphadenopathy, no thyromegaly.
**Cardiovascular:** Regular rate and rhythm, no murmurs, rubs, or gallops.
**Lungs:** Clear to auscultation bilaterally, no wheezes, rales, or rhonchi.
**Abdomen:** Soft, non-tender, non-distended, normoactive bowel sounds.
**Extremities:** No edema, good peripheral pulses.
**Skin:** Warm and dry, good turgor, no rashes.

---

## Lab Results

### Complete Blood Count (CBC)
*   **White Blood Cell (WBC) Count:** 7.2 x 10^9/L (Ref: 4.0-10.0)
*   **Red Blood Cell (RBC) Count:** 4.5 x 10^12/L (Ref: 4.2-5.4)
*   **Hemoglobin:** 11.5 g/dL (Ref: 12.0-15.0)
*   **Hematocrit:** 34.0% (Ref: 36.0-45.0)
*   **Platelet Count:** 250 x 10^9/L (Ref: 150-450)

### Comprehensive Metabolic Panel (CMP)
*   **Glucose:** 90 mg/dL
*   **BUN:** 15 mg/dL
*   **Creatinine:** 0.8 mg/dL
*   **Sodium:** 140 mEq/L
*   **Potassium:** 4.0 mEq/L
*   **Chloride:** 102 mEq/L
*   **CO2:** 24 mEq/L
*   **Calcium:** 9.5 mg/dL
*   **Total Protein:** 7.0 g/dL
*   **Albumin:** 4.0 g/dL
*   **Total Bilirubin:** 0.5 mg/dL
*   **Alkaline Phosphatase:** 80 U/L
*   **AST:** 25 U/L
*   **ALT:** 20 U/L

### Other Labs
*   **Thyroid Stimulating Hormone (TSH):** 3.8 mIU/L (Ref: 0.4-4.0)
*   **Ferritin:** 15 ng/mL (Ref: 20-200)
*   **Vitamin B12:** 250 pg/mL (Ref: 200-900)
*   **Folate:** 8.0 ng/mL (Ref: >4.0)

---

## Imaging Results

No imaging results available.

---

## Diagnosis

*   **D50.9:** Iron deficiency anemia, unspecified
*   **R53.81:** Fatigue

---

## Treatment Plan

Initiate oral iron supplementation (Ferrous Sulfate 325 mg) once daily. Advise on dietary modifications to increase iron intake (e.g., red meat, leafy greens, fortified cereals) and vitamin C intake to enhance absorption. Re-evaluate symptoms and repeat CBC and Ferritin levels in 6 weeks. Discuss potential causes of iron deficiency.

---

## Medications

*   **Name:** Ferrous Sulfate
    *   **Dosage:** 325 mg
    *   **Frequency:** Once daily
    *   **Duration:** 6 weeks

---

## Follow-up Instructions

Patient is advised to schedule a follow-up appointment in 6 weeks for re-evaluation of symptoms and repeat blood tests (CBC, Ferritin). Patient should be educated on common side effects of iron supplementation (e.g., constipation, dark stools) and strategies to manage them. Emphasize importance of adherence to medication and dietary changes.

---

## Notes

Patient expressed concern regarding persistent fatigue impacting daily activities. Seems motivated to follow recommendations. Discussed importance of ongoing monitoring.